U.S. flag

An official website of the United States government

NM_000141.5(FGFR2):c.755C>T (p.Ser252Leu) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Jan 1, 2023
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002298724.14

Allele description [Variation Report for NM_000141.5(FGFR2):c.755C>T (p.Ser252Leu)]

NM_000141.5(FGFR2):c.755C>T (p.Ser252Leu)

Gene:
FGFR2:fibroblast growth factor receptor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q26.13
Genomic location:
Preferred name:
NM_000141.5(FGFR2):c.755C>T (p.Ser252Leu)
Other names:
NM_000141.4:c.755C>T(p.Ser252Leu); NM_001144913.1:c.755C>T(p.Ser252Leu); NM_001144915.1:c.488C>T(p.Ser163Leu); NM_001144916.1:c.410C>T(p.Ser137Leu); NM_001144917.1:c.755C>T(p.Ser252Leu); NM_001144918.1:c.410C>T(p.Ser137Leu); NM_001144919.1:c.488C>T(p.Ser163Leu); NM_022970.3:c.755C>T(p.Ser252Leu); NM_023029.2:c.488C>T(p.Ser163Leu)
HGVS:
  • NC_000010.11:g.121520163G>A
  • NG_012449.2:g.83296C>T
  • NM_000141.5:c.755C>TMANE SELECT
  • NM_001144913.1:c.755C>T
  • NM_001144914.1:c.749-4844C>T
  • NM_001144915.2:c.488C>T
  • NM_001144916.2:c.410C>T
  • NM_001144917.2:c.755C>T
  • NM_001144918.2:c.410C>T
  • NM_001144919.2:c.488C>T
  • NM_001320654.2:c.71C>T
  • NM_001320658.2:c.755C>T
  • NM_022969.1:c.755C>T
  • NM_022970.4:c.755C>T
  • NM_023029.2:c.488C>T
  • NP_000132.3:p.Ser252Leu
  • NP_000132.3:p.Ser252Leu
  • NP_001138385.1:p.Ser252Leu
  • NP_001138387.1:p.Ser163Leu
  • NP_001138388.1:p.Ser137Leu
  • NP_001138389.1:p.Ser252Leu
  • NP_001138390.1:p.Ser137Leu
  • NP_001138391.1:p.Ser163Leu
  • NP_001307583.1:p.Ser24Leu
  • NP_001307587.1:p.Ser252Leu
  • NP_075258.1:p.Ser252Leu
  • NP_075259.4:p.Ser252Leu
  • NP_075259.4:p.Ser252Leu
  • NP_075418.1:p.Ser163Leu
  • LRG_994t1:c.755C>T
  • LRG_994t2:c.755C>T
  • LRG_994:g.83296C>T
  • LRG_994p1:p.Ser252Leu
  • LRG_994p2:p.Ser252Leu
  • NC_000010.10:g.123279677G>A
  • NM_000141.4:c.755C>T
  • NM_000141.5:c.755C>T
  • NM_022970.3:c.755C>T
  • NR_073009.2:n.1043C>T
Protein change:
S137L
Links:
dbSNP: rs79184941
NCBI 1000 Genomes Browser:
rs79184941
Molecular consequence:
  • NM_001144914.1:c.749-4844C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000141.5:c.755C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144913.1:c.755C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144915.2:c.488C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144916.2:c.410C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144917.2:c.755C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144918.2:c.410C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144919.2:c.488C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001320654.2:c.71C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001320658.2:c.755C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_022969.1:c.755C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_022970.4:c.755C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_023029.2:c.488C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_073009.2:n.1043C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002588317GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Uncertain significance
(Oct 14, 2022)
germlineclinical testing

Citation Link,

SCV004134775CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Likely benign
(Jan 1, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV002588317.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Reported in individuals with Crouzon syndrome, inherited from apparently unaffected parents (Oldridge et al., 1997; Ohishi et al., 2017); Reported in a family where affected members had severe syndactyly without craniosynostosis and harbored a second FGFR2 variant in cis with p.(S252L) (Wilkie et al., 2002).; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 15282208, 15840724, 9700203, 26003532, 17621648, 9300656, 27683237, 32908727, 31348830, 9002682, 12357470, 29037998, 20301628)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV004134775.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

FGFR2: BS1

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Nov 10, 2024